Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2012 Oct 8;172(18):1412-14.
doi: 10.1001/archinternmed.2012.4306.

Observational comparative effectiveness studies of drug therapies: high-quality answers or important clinical questions?: comment on "Comparative effectiveness of 2 β-blockers in hypertensive patients"

James S Floyd  1 , Bruce M Psaty
Affiliations
Comment

Observational comparative effectiveness studies of drug therapies: high-quality answers or important clinical questions?: comment on "Comparative effectiveness of 2 β-blockers in hypertensive patients"

James S Floyd et al. Arch Intern Med. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts: Dr. Psaty serves on the Data Safety and Monitoring Board for a clinical trial of a device funded by Zoll LifeCor, and on the Steering Committee for the Yale Open Data Access Project funded by Medtronic. Previously, Dr. Psaty served as a consultant to the Cardiovascular Research Network.

Comment on

References

    1. Freemantle N, Cleland J, Young P, Mason J, Harrison J. beta Blockade after myocardial infarction: systematic review and meta regression analysis. Bmj. 1999 Jun 26;318(7200):1730–1737. - PMC - PubMed
    1. McAlister FA, Wiebe N, Ezekowitz JA, Leung AA, Armstrong PW. Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure. Ann Intern Med. 2009 Jun 2;150(11):784–794. - PubMed
    1. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. Jama. 2003 May 21;289(19):2560–2572. - PubMed
    1. Psaty BM, Weiss NS, Furberg CD. Recent trials in hypertension: compelling science or commercial speech? Jama. 2006 Apr 12;295(14):1704–1706. - PubMed
    1. Dahlof B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002 Mar 23;359(9311):995–1003. - PubMed

Publication types

Substances

LinkOut - more resources